Inventor · disambiguated record
Stephen J. Tapscott
Also filed as: TAPSCOTT STEPHEN · TAPSCOTT STEPHEN J · TAPSCOTT STEPHEN JUSTICE
9 granted patents·13 pending applications·189 citations·filing 1991–2022
89Inventor score
Files withHUTCHINSON FRED CANCER RES12FRED HUTCHINSON CANCER CENTER3TAPSCOTT STEPHEN J2UNIV SAINT LOUIS2ACADEMISCH ZIEKENHUIS LEIDEN1
Top patents by PatentIndex Score
22 records- 0194US10538763B2Compounds and methods for modulation of DUX4IONIS PHARMACEUTICALS INC·Filed 2016·Granted Jan 21, 2020·21 cites·17 claims
- 0287US5795723AExpression of neurogenic bHLH genes in primitive neuroectodermal tumorsHUTCHINSON FRED CANCER RES·Filed 1997·Granted Aug 18, 1998·58 cites·6 claims
- 0385US10865445B2Methods for alleviating facioscapulohumeral dystrophy (FSHD) by N siRNA molecule inhibiting the expression of DUX4-FLVAN DER MAAREL SILVERE M·Filed 2011·Granted Dec 15, 2020·29 cites·5 claims
- 0485US9814728B2Inhibition of DUX4 expression using bromodomain and extra-terminal domain protein inhibitors (BETi)UNIV SAINT LOUIS·Filed 2014·Granted Nov 14, 2017·8 cites·11 claims
- 0584US6444463B1Neurogenic differentiation gene neurod3 and methods for inducing differentiation of cellsHUTCHINSON FRED CANCER RES·Filed 2000·Granted Sep 3, 2002·17 cites·6 claims
- 0672US5695995ANeurogenic differentiation (neurod) genesHUTCHINSON FRED CANCER RES·Filed 1995·Granted Dec 9, 1997·38 cites·8 claims
- 0760US2025339531A1Dux4 polypeptides and nucleic acids for treating inflammatory and autoimmune conditionsFRED HUTCHINSON CANCER CENTER·Filed 2022·Application pending·0 cites
- 0859US5352595AMyod regulatory regionHUTCHINSON FRED CANCER RES·Filed 1991·Granted Oct 4, 1994·18 cites·13 claims
- 0959US2021198739A1Methods for determining the presence or risk of developing facioscapulohumeral dystrophy (fshd)HUTCHINSON FRED CANCER RES·Filed 2020·Application pending·0 cites
- 1055US8597880B2Methods and compositions for identifying increased risk of developing fragile X-associated disordersTAPSCOTT STEPHEN J·Filed 2008·Granted Dec 3, 2013·0 cites·2 claims
- 1155US2010273151A1Genome-wide analysis of palindrome formation and dna methylationHUTCHINSON FRED CANCER RES·Filed 2009·Application pending·0 cites
- 1255US2025195673A1Compositions and methods for selective depletion of target moleculesFRED HUTCHINSON CANCER CENTER·Filed 2021·Application pending·0 cites
- 1353US2014141439A1Methods and compositions for identifying increased risk of developing fragile x-associated disordersHUTCHINSON FRED CANCER RES·Filed 2013·Application pending·0 cites
- 1446US2015166961A1Ex vivo expansion of myogenic stem cells by notch activationHUTCHINSON FRED CANCER RES·Filed 2013·Application pending·0 cites
- 1544US12458668B2Methods for treating facioscapulohumeral muscular dystrophyFRED HUTCHINSON CANCER CENTER·Filed 2019·Granted Nov 4, 2025·0 cites·4 claims
- 1642US2015159216A1Methods and compositions related to the smchd1 geneHUTCHINSON FRED CANCER RES·Filed 2013·Application pending·0 cites
- 1742US2022202845A1Methods and compositions for treating cancerHUTCHINSON FRED CANCER RES·Filed 2019·Application pending·0 cites
- 1840US2020297696A1P38 inhibitors for the treatment of fshdUNIV SAINT LOUIS·Filed 2018·Application pending·0 cites
- 1939US2006088850A1Method for genome-wide analysis of palindrome formation and uses thereofHUTCHINSON FRED CANCER RES·Filed 2005·Application pending·0 cites
- 2039US2018147256A1Means and methods for treating facioscapulohumeral muscular dystrophy (fshd).ACADEMISCH ZIEKENHUIS LEIDEN·Filed 2016·Application pending·0 cites
- 2136US2014242093A1Methods and compositions for modulating the innate immune response and/or myogenesis in a mammalian subjectTAPSCOTT STEPHEN J·Filed 2012·Application pending·0 cites
- 2235US2020087629A1Compositions and methods for reprogramming cells and for somatic cell nuclear transfer using duxc expressionHUTCHINSON FRED CANCER RES·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephen J. Tapscott files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →